Oct 8, 2018 8:00 am EDT Nemus Bioscience Announces that Emerald Health Sciences has Provided a Credit Facility of up to $20 Million and Adopted an Open Market Share Purchase Program of up to 10 Million Common Shares
Aug 28, 2018 8:00 am EDT NEMUS Bioscience to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
Aug 1, 2018 9:54 am EDT UPDATE: Nemus Bioscience, Inc. Signs Agreement with Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredient for Glaucoma
Aug 1, 2018 8:30 am EDT Nemus Bioscience, Inc. Signs Agreement with Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredient for Glaucoma
Mar 21, 2018 8:30 am EDT Prominent Salk Institute Neuroscientist Joins Nemus Bioscience as Scientific Consultant
Mar 7, 2018 8:30 am EST NEMUS Bioscience to Participate in Sachs BioCapital USA Forum at the New York Academy of Sciences